Anheuser-Busch InBev (ENXTBR:ABI) is drawing fresh attention after announcing a $4 million investment in its Idaho Falls operations and a $50,000 grant to the University of Idaho for barley research.
See our latest analysis for Anheuser-Busch InBev.
The latest Idaho investment comes as Anheuser-Busch InBev’s share price has climbed to €70.72, with a 90-day share price return of 9.51% and a year-to-date share price return of 30.00%. The 1-year total shareholder return sits at 22.64%, suggesting that momentum has been building over both shorter and longer periods.
If you are looking for other ideas after reading about Anheuser-Busch InBev, this could be a good moment to scan the market for resilient businesses via the 106 top founder-led companies
Anheuser-Busch InBev now trades around €70.72, with analysts collectively pointing to about €80 as fair value and one model implying a far larger gap. Is that simply caution at work, or is it grounded in a more specific assessment of risk?
At a share price of €70.72, the most followed narrative on Anheuser-Busch InBev points to a fair value of €89.45, framing the current market level as a sizeable discount based on a detailed long term view of the business.
ABI is transitioning into:
a premiumized portfolio
a more efficient operating system
a deleveraged balance sheet
In other words:
ABI is becoming a cash flow machine with improving quality.
If execution continues, valuation expansion + margin expansion + dividends create a triple compounding effect.
The heart of this valuation is not a single line in the income statement. It leans on a specific blend of long term revenue growth, higher profit margins and a future earnings multiple that together support a much higher fair value than today’s price suggests. The full narrative connects those assumptions into one cohesive roadmap for Anheuser-Busch InBev’s cash generation profile.
Result: Fair Value of €89.45 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this optimistic Anheuser-Busch InBev narrative could be challenged if premiumisation stalls, or if cost cuts and digital efficiency gains prove harder to sustain.
Find out about the key risks to this Anheuser-Busch InBev narrative.
With both optimism and caution running through the Anheuser-Busch InBev story, it makes sense to review the full picture yourself and decide how the trade off between its risks and rewards fits your own approach, starting with the 3 key rewards and 1 important warning sign.
If Anheuser-Busch InBev has you thinking more broadly about your portfolio, consider using this time to look for other opportunities before they move out of reach.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com